RxDoctor Payments DataLook up a doctor →

Alan Hirahara, MD

Orthopaedic Surgery · Sacramento, CANPI 1336139435

Payments from drug & device makers

$3,352,199in general payments, 2019–2025

Across 449 payments — averaging $7465.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3.3M
  • Clarius Mobile Health Corp.$8K
  • Sequoia Surgical, Inc.$6K
  • Evolution Surgical, Inc$1K
  • Zimmer Biomet$111
$16,520in research payments, 2019–2025

Across 1 payment — averaging $16,520 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$17K

What the payments were for

  • Royalty or licence$2,914,80787%
  • Consulting fees$91,7353%
  • Speaking & faculty fees$303,6959%
  • Travel & lodging$27,5711%
  • Food & beverage$7,1700%
  • Education$7,2220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,352,199 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$67,656
Medicare patients
127
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$300
Ibuprofen13$170
Naproxen17$124
Cyclobenzaprine Hcl18$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →